CYP3A4/5 and pharmacogenetics in patients with sarcoma
- PMID: 17679078
- DOI: 10.1016/S1470-2045(07)70215-2
CYP3A4/5 and pharmacogenetics in patients with sarcoma
Comment on
-
Opportunities for improving the therapeutic ratio for patients with sarcoma.Lancet Oncol. 2007 Jun;8(6):513-24. doi: 10.1016/S1470-2045(07)70169-9. Lancet Oncol. 2007. PMID: 17540303 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
